They expected an R&D tax incentive of $731,830 this Quarter and none was actually received last quarter; only $350K in the first
quarter bring a YTD figure of $1,802K.
Also $15,000 per month in license fees are received quarterly in arrears so this would be due to timing differences.
$50,000 per month from consulting fees to support the reseller might have been invoiced already by the Company but would still be outstanding,,,
- Forums
- ASX - By Stock
- NET
- Ann: Appendix 4C - quarterly
NET
netlinkz limited
Add to My Watchlist
0.00%
!
0.3¢

Ann: Appendix 4C - quarterly, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.63M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NET (ASX) Chart |
Day chart unavailable
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online